UnknownPHASE1, PHASE2NCT02323789

Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa

Studying Dystrophic epidermolysis bullosa

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
King's College London
Principal Investigator
John McGrath, FRCP/FSci/MD
King's College London
Intervention
Mesenchymal stromal cells(drug)
Enrollment
10 enrolled
Eligibility
18-65 years · All sexes
Timeline
2015 – 2017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02323789 on ClinicalTrials.gov

Other trials for Dystrophic epidermolysis bullosa

Additional recruiting or active studies for the same condition.

See all trials for Dystrophic epidermolysis bullosa →

← Back to all trials